Effect of low-level laser therapy (808 nm) on markers of muscle damage: a randomized double-blind placebo-controlled trial

Author(s):  
Amanda Soares Felismino ◽  
Eduardo Caldas Costa ◽  
Marcelo Saldanha Aoki ◽  
Cleber Ferraresi ◽  
Telma Maria de Araújo Moura Lemos ◽  
...  
2016 ◽  
Vol 31 (9) ◽  
pp. 1935-1942 ◽  
Author(s):  
Carolina Gassen Fritsch ◽  
Maurício Pinto Dornelles ◽  
Lucas Severo-Silveira ◽  
Vanessa Bernardes Marques ◽  
Isabele de Albuquerque Rosso ◽  
...  

2016 ◽  
Vol 32 (1) ◽  
pp. 251-251
Author(s):  
Carolina Gassen Fritsch ◽  
Maurício Pinto Dornelles ◽  
Lucas Severo-Silveira ◽  
Vanessa Bernardes Marques ◽  
Isabele de Albuquerque Rosso ◽  
...  

VASA ◽  
2002 ◽  
Vol 31 (2) ◽  
pp. 91-94 ◽  
Author(s):  
Hirschl ◽  
Katzenschlager ◽  
Ammer ◽  
Melnizky ◽  
Rathkolb ◽  
...  

Background: No causal treatment of primary Raynaud’s phenomenon is available due to its unclear aetiology. Low level laser therapy (LLLT) is applied in a multitude of medical conditions often without sufficient evidence of efficacy and established mechanisms. To asses the effect of this therapy in patients with primary Raynaud’s phenomenon a randomised, double blind, placebo controlled cross over study was designed. Patients and methods: Absolute and relative frequency and intensity of vasospastic attacks during three weeks of either LLLT or placebo therapy and results of infrared thermography before onset and at the end of both therapy sequences were evaluated in 15 patients with primary Raynaud’s phenomenon. Results: Frequency of Raynaud’s attacks was not significantly affected by low level laser therapy. Compared to placebo a significantly lower intensity of attacks during laser irradiation was observed, but no transfer effect occurred. Additionally the mean temperature gradient after cold exposure was reduced after laser irradiation, while the number of fingers showing prolonged rewarming was unaffected. Conclusion: Though further studies are necessary to confirm these results we could demonstrate for the first time in a double blind placebo controlled clinical trial that low laser therapy is a potential candidate for an effective therapy of Raynaud`s phenomenon, although effects seem to be of short duration.


Pain Medicine ◽  
2010 ◽  
Vol 11 (8) ◽  
pp. 1169-1178 ◽  
Author(s):  
Ljubica M. Konstantinovic ◽  
Milisav R. Cutovic ◽  
Aleksandar N. Milovanovic ◽  
Stevan J. Jovic ◽  
Aleksandra S. Dragin ◽  
...  

2010 ◽  
Vol 29 (5) ◽  
pp. 501-509 ◽  
Author(s):  
Sandra Mara Meireles ◽  
Anamaria Jones ◽  
Fabio Jennings ◽  
Alina Lica Suda ◽  
Nivaldo Antônio Parizotto ◽  
...  

2011 ◽  
Vol 30 (10) ◽  
pp. 1341-1346 ◽  
Author(s):  
Seyyed Mohammad Jalil Abrisham ◽  
Mohammad Kermani-Alghoraishi ◽  
Rahil Ghahramani ◽  
Latife Jabbari ◽  
Hossein Jomeh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document